The report “Pharmaceutical Excipients Market, by Product (Organic Chemicals and Inorganic Chemicals), by Functionality (Fillers and Diluents, Binders, Disintegrants, Lubricants And Glidants, and Others (Coating Agents, Preservatives, Emulsifying Agents, and Flavoring Agents And Sweeteners)), by Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, and Others (Vaginal Inhaled, Ophthalmic, and Optic)), and Region – Global Forecast to 2029″ The Global Pharmaceutical Excipients Market accounted for US$ 6.52 billion 2020 and is estimated to be US$ 10.49 billion by 2030 and is anticipated to register a CAGR of 5.3%. This is attributed to excipients have been provide better functionality and competitive advantage in drug formulations in turns increases demand from pharmaceutical industry. Furthermore, rising demand for generic medicine across the globe the global pharmaceutical excipients market. Key Highlights: On December 2016, Merck & Co., Inc launched “Parteck MXP” which is a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active. On February 5, 2019, ABITEC Corporation launched “CAPMUL GDB EP/NF”. This is high-purity, highly-reproducible solid lipid exipient which offers good flow and uniform particle size distribution for use in multiple fomrulations, including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids. Key Market Insights from the report:           The pharmaceutical excipients market […] read more